Studies show that decubitus ulcers can develop in 9–13% of hospitalized patients, 41% of intensive-care patients, 60% of quadriplegic patients and 66% of elderly hip-fracture patients.
Decubitus ulcers are a health problem that prolongs hospital stays, increases hospital costs and raises patient mortality risk. The intensive-care anti-decubitus air systems we manufacture — the product of advanced technology and extensive research — aim to reduce all of these adverse outcomes.
The RovaCare devices we manufacture and sell meet all the safety standards required by today's modern hospitals. Produced with domestic technology, our devices have been used with high efficiency since 2016 in Ministry of Health training and research hospitals, university hospitals, public and private hospitals, and home care.
Models — Click a model for details
